KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Labcorp Holdings (LH) EBIT (2016 - 2025)

Labcorp Holdings (LH) has disclosed EBIT for 17 consecutive years, with $267.6 million as the latest value for Q4 2025.

  • Quarterly EBIT rose 23.6% to $267.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 billion through Dec 2025, up 27.42% year-over-year, with the annual reading at $1.4 billion for FY2025, 27.42% up from the prior year.
  • EBIT hit $267.6 million in Q4 2025 for Labcorp Holdings, down from $396.6 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $1.1 billion in Q1 2021 to a low of -$122.8 million in Q4 2023.
  • Historically, EBIT has averaged $388.2 million across 5 years, with a median of $327.9 million in 2023.
  • Biggest five-year swings in EBIT: skyrocketed 649.27% in 2021 and later tumbled 530.88% in 2023.
  • Year by year, EBIT stood at $519.7 million in 2021, then crashed by 94.52% to $28.5 million in 2022, then crashed by 530.88% to -$122.8 million in 2023, then surged by 276.3% to $216.5 million in 2024, then increased by 23.6% to $267.6 million in 2025.
  • Business Quant data shows EBIT for LH at $267.6 million in Q4 2025, $396.6 million in Q3 2025, and $394.5 million in Q2 2025.